The business case of biodiversity

Bringing together representatives from the pharmaceutical, agricultural biotechnology, industrial biotechnology, animal health, cosmetics, and biocontrol sectors, this event will foster diverse discussions on key industry topics
This event will feature a variety of presentations, panel discussions, and fishbowl sessions designed to foster interaction between experts and the audience. Each session will include 3 to 4 presentations followed by an interactive discussion.

We aim to gather a diverse group of representatives from the private sector and various institutions, including those from the pharmaceutical, agricultural biotechnology, industrial biotechnology, animal health, cosmetics, and biocontrol sectors. This diversity will ensure a rich exchange of perspectives, both during scheduled sessions and organically.

March 25th will start in the afternoon and focus on sustainability and biodiversity in asset management, supply chains, and related reporting obligations. The morning of March 26th will focus on Access and Benefit-Sharing (ABS), with presentations on the Nagoya Protocol's 10-year review and applied compliance. The afternoon of March 26th will focus on Digital Sequence Information (DSI), with discussions on the outcomes from the CBD COP in Cali, company experiences, and future steps.
https://3bio.eu/wp-content/uploads/2023/06/portal.png
https://3bio.eu/wp-content/uploads/2023/06/wizard.png

Practical information

Text on venue, dates and prices

Our speakers

https://3bio.eu/wp-content/uploads/2025/01/GetAttachmentThumbnail-1208x1280.jpg

RobecoAnouk in 't Veld - van Zanten

Anouk is Director Product Development Equity at Robeco. In the capacity of overseeing Robeco’s Equity product suite, Anouk is actively engaged in integrating sustainability data and insights into mutual funds and ETFs. Anouk played a vital role in adopting the Sustainable Finance Disclosure Regulation (SFDR) and has in-depth knowledge of the European sustainable regulatory landscape and the impact on the financial industry. Previously, Anouk worked in the areas of Active Ownership and socio-economic impact measurement. With her presentation, Anouk will focus on the role of asset managers in bridging the biodiversity finance gap, and how European regulation plays a role in managing biodiversity-related risks and opportunities in portfolios.
https://3bio.eu/wp-content/uploads/2023/06/3BIO-03-small.png

Coming soon

https://3bio.eu/wp-content/uploads/2023/06/3BIO-03-small.png

Coming soon

https://3bio.eu/wp-content/uploads/2023/06/3BIO-03-small.png

Coming soon

HoursMinutesSeconds